» Articles » PMID: 29056500

Emerging Role of Non-coding RNA in Oral Cancer

Overview
Journal Cell Signal
Date 2017 Oct 24
PMID 29056500
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinoma (OSCC) is characterized by genomic and epigenomic alterations. However, the mechanisms underlying oral squamous cell carcinoma tumorigenesis and progression remain to be elucidated. Long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and extracellular RNAs (exRNAs) are emerging groups of regulatory RNAs, which possess low or no protein-coding potential. Emerging lines of evidence indicates that deregulated expression of lncRNAs and circular RNAs are associated with the induction and progression of various cancers, including oral cancer, through epigenetic, transcriptional, and post-transcriptional alterations. In this review, we highlight the expression and functional roles of extracellular RNAs, lncRNAs, and circular RNAs in oral squamous cell carcinoma and discuss their potential clinical applications as diagnostic or prognostic biomarkers, and therapeutic targets.

Citing Articles

EBV-Induced LINC00944: A Driver of Oral Cancer Progression and Influencer of Macrophage Differentiation.

Srisathaporn S, Ekalaksananan T, Heawchaiyaphum C, Aromseree S, Maranon D, Altina N Cancers (Basel). 2025; 17(3).

PMID: 39941858 PMC: 11815735. DOI: 10.3390/cancers17030491.


Non-coding RNAs in oral cancer: Emerging biomarkers and therapeutic frontier.

Hashemi M, Khoushab S, Hobabi Aghmiuni M, Anaraki S, Alimohammadi M, Taheriazam A Heliyon. 2024; 10(21):e40096.

PMID: 39583806 PMC: 11582460. DOI: 10.1016/j.heliyon.2024.e40096.


Natural compounds targeting miRNAs: a novel approach in oral cancer therapy.

Doghish Y, Doghish A, Mageed S, Mohammed O, Hamza T, Abdelaziz A Funct Integr Genomics. 2024; 24(6):202.

PMID: 39455476 DOI: 10.1007/s10142-024-01473-1.


Unlocking the Therapeutic Potential of Oral Cancer Stem Cell-Derived Exosomes.

Kumar P, Lakhera R, Aggarwal S, Gupta S Biomedicines. 2024; 12(8).

PMID: 39200273 PMC: 11351673. DOI: 10.3390/biomedicines12081809.


m6A-dependent mature miR-151-5p accelerates the malignant process of HNSCC by targeting LYPD3.

Huang F, Ren Y, Hua Y, Wang Y, Li R, Ji N Mol Biomed. 2024; 5(1):27.

PMID: 39009906 PMC: 11250566. DOI: 10.1186/s43556-024-00189-9.